Analysis Of Income And Expense [Abstract]

Novonesis AS - Filing #1443478

Concept	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	—	14,012,000,000 DKK	—	—	—	—	—	—	—	14,374,000,000 DKK	—	—
Material income and expense [abstract]
Research and development expense	—	1,937,000,000 DKK	—	—	—	—	—	—	—	1,966,000,000 DKK	—	—
Other operating income (expense)	—	56,000,000 DKK	—	—	—	—	—	—	—	520,000,000 DKK	—	—
Miscellaneous other comprehensive income [abstract]
Income tax relating to exchange differences on translation of foreign operations and hedges of net investments in foreign operations included in other comprehensive income [abstract]
Income tax relating to exchange differences on translation of foreign operations included in other comprehensive income	—	1,000,000 DKK	—	—	—	—	—	—	—	1,000,000 DKK	—	—
Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract]
Share of profit (loss) of associates accounted for using equity method	—	4,000,000 DKK	—	—	—	—	—	—	—	5,000,000 DKK	—	—
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	2,825,000,000 DKK	2,149,000,000 DKK	784,000,000 DKK	- DKK	108,000,000 DKK	2,149,000,000 DKK	143,000,000 DKK	3,342,000,000 DKK	3,154,000,000 DKK	3,342,000,000 DKK	- DKK	45,000,000 DKK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	—	2,149,000,000 DKK	—	—	—	—	—	—	—	3,342,000,000 DKK	—	—
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests	—	- DKK	—	—	—	—	—	—	—	- DKK	—	—